Symptomatic slow-acting drugs for osteoarthritis: what are the facts?-Reference-Cited by-同舟云学术

Symptomatic slow-acting drugs for osteoarthritis: what are the facts?

Published:2006-12 Issue:6 Volume:73 Page:606-609
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Dougados Maxime

Publisher

Elsevier BV

Subject

Rheumatology

Reference32 articles.

1. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop;Altman;Osteoarthritis Cartilage,1996

2. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III;Bellmay;J. Rheumatol.,1997

3. Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative;Dougados;Osteoarthritis Cartilage,2005

4. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited;Pham;Osteoarthritis Cartilage,2004

5. Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria;Pham;J. Rheumatol.,2003

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic inflammatory biomarkers are novel predictors of all-cause and cardiovascular mortality in individuals with osteoarthritis: a prospective cohort study using data from the NHANES;BMC Public Health;2024-06-13

2. Nucleic Acid Nanomaterials-based Therapy for Osteoarthritis: Progress and Prospects;Current Drug Metabolism;2023-05

3. Glucosamine as a Treatment for Osteoarthritis: What If It’s True?;Frontiers in Pharmacology;2022-03-17

4. Chondroitin sulfate in therapy osteoarthritis chronic pain patients according to actual clinical recommendations;Terapevticheskii arkhiv;2021-12-15

5. Topical nonsteroidal anti-inflammatory drugs for management of pain syndrome;Meditsinskiy sovet = Medical Council;2021-12-01